Skip to content
On this page:OverviewPublicationsKey papers
PICO Portalanswers from OpenAlex & ORCID

Shingo Matsumoto

ResearcherPublications, citations & collaboration network

Shingo Matsumoto is a researcher indexed in PICO Portal from OpenAlex & ORCID.

How many works does Shingo Matsumoto have?

PICO Portalindexed works

Shingo Matsumoto has 753 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Shingo Matsumoto have?

PICO Portalcitation count

Shingo Matsumoto has 12,950 citations in the OpenAlex counts PICO Portal stores.

What is the h-index of Shingo Matsumoto?

PICO Portalh-index

Shingo Matsumoto has an h-index of 58 in OpenAlex.

What is the i10-index of Shingo Matsumoto?

PICO Portali10-index

Shingo Matsumoto has an i10-index of 235 in OpenAlex.

What is the ORCID of Shingo Matsumoto?

PICO Portalorcid

The ORCID for Shingo Matsumoto is on the source record.

What is the OpenAlex record for Shingo Matsumoto?

PICO Portalopenalex

The OpenAlex for Shingo Matsumoto is on the source record.

What are the most-cited papers on Shingo Matsumoto?

PICO Portalmost cited works
Effects of Water Management on Cadmium and Arsenic Accumulation and Dimethylarsinic Acid Concentrations in Japanese Rice
Tomohito Arao, Akira Kawasaki, Koji Baba, Shinsuke Mori, Shingo Matsumoto
Environmental Science & Technology. 2009564 Citations
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
Mohanraj Rajesh, Partha Mukhopadhyay, Sándor Bátkai, Vivek Patel, Keita Saito, Shingo Matsumoto, Yoshihiro Kashiwaya, Béla Horváth, Bani Mukhopadhyay, Lauren Becker, György Haskó, Lucas Liaudet, David A. Wink, Aristidis Veves, Raphael Mechoulam, Pál Pacher
Journal of the American College of Cardiology. 2010491 CitationsOPEN ACCESS
Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial
Kiyotaka Yoh, Takashi Seto, Miyako Satouchi, Makoto Nishio, Noboru Yamamoto, Haruyasu Murakami, Naoyuki Nogami, Shingo Matsumoto, Takashi Kohno, Koji Tsuta, Katsuya Tsuchihara, Genichiro Ishii, Shogo Nomura, Akihiro Sato, Atsushi Ohtsu, Yuichiro Ohe, Kōichi Goto
The Lancet Respiratory Medicine. 2016297 Citations
Prevalence and specificity of LKB1 genetic alterations in lung cancers
Shingo Matsumoto, Reika Iwakawa, Kenji Takahashi, Takashi Kohno, Yukihiro Nakanishi, Yoshihiro Matsuno, Kenji Suzuki, Masaru Nakamoto, Eiji Shimizu, John D. Minna, Jun Yokota
Oncogene. 2007283 Citations
Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer.
Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Kōichi Goto
PubMed. 2015271 CitationsOPEN ACCESS

Related on PICO Portal

470M+ articles · 14-day free trial